Neglected Tropical Disease Treatment Market

May 2021 | DMG00027A

The report focused on the different diseases of neglected tropical disease and the type of drugs and vaccines used for treating the disease. The report also focuses on the initiatives takes by the government and non-government regulatory authorities. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for neglected tropical disease treatment market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each by disease, product type, route of administration, end-user and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional neglected tropical disease treatment markets; it explains the major market drivers of the global neglected tropical disease treatment industry, current trends within the industry, major applications, and the regional dynamics of the global neglected tropical disease treatment market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global neglected tropical disease treatment market.

Report Includes

41 tables and 49 figures
An up-to-date analysis of the Global Neglected Tropical Disease Treatment Market.
Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
Estimation of market size and revenue forecast for Global Neglected Tropical Disease Treatment Market, and corresponding market share analysis by disease, product type, route of administration, end-user, and region.
Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Neglected Tropical Disease Treatment, identification of the companies that are best positioned to meet this demand.
In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
Identification of promising new vaccines, and drugs still in the development and testing stages, and their probability of successful commercial launch within the next five years
Impact of COVID-19 on the Neglected Tropical Disease Treatment Market as compared to overall global economy.
Insight into the growth development strategies of major Neglected Tropical Disease Treatment manufacturers and their key competitive landscape
Descriptive company profiles of the leading market participants, including F. Hoffmann-La Roche AG, Sanofi S.A., Eisai Co. Ltd., Pfizer, Inc., Novartis International AG, GlaxoSmithKline plc, Bayer AG, Abbott Laboratories, and others.

Neglected Tropical Disease Treatment Market

Single User License: $2750

Enquiry Before Buying

Table 1 : Global Neglected Tropical Disease Treatment Market, Through 2026
Table 2 : Global Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 3 : Global Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 4 : Global Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 5 : Global Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 6 : Global Neglected Tropical Disease Treatment Market, by Region, Through 2026
Table 7 : North America Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 8 : North America Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 9 : North America Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 10 : North America Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 11 : North America Neglected Tropical Disease Treatment Market, by Country, Through 2026
Table 12 : Europe Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 13 : Europe Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 14 : Europe Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 15 : Europe Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 16 : Europe Neglected Tropical Disease Treatment Market, by Country, Through 2026
Table 17 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 18 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 19 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 20 : Asia-Pacific Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 21 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Country, Through 2026
Table 22 : South America Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 23 : South America Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 24 : South America Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 25 : South America Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 26 : South America Neglected Tropical Disease Treatment Market, by Country, Through 2026
Table 27 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Disease, Through 2026
Table 28 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Product Type, Through 2026
Table 29 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Route of Administration, Through 2026
Table 30 : Middle East & Africa Neglected Tropical Disease Treatment Market, by End-User, Through 2026
Table 31 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Country, Through 2026
Table 32 : F. Hoffmann-La Roche AG: Financial Performance, Through 2020
Table 33 : Sanofi S.A.: Financial Performance, Through 2020
Table 34 : Eisai Co. Ltd.: Financial Performance, Through 2020
Table 35 : Pfizer, Inc.: Financial Performance, Through 2020
Table 36 : Novartis International AG: Financial Performance, Through 2020
Table 37 : GlaxoSmithKline plc: Financial Performance, Through 2020
Table 38 : Bayer AG: Financial Performance, Through 2020
Table 39 : Abbott Laboratories: Financial Performance, Through 2020
Table 40 : StratifiCare Pte. Ltd.: Financial Performance, Through 2020
Table 41 : Takeda Pharmaceutical Company Limited: Financial Performance, Through 2020

Figure 1 : Global Neglected Tropical Disease Treatment Market
Figure 2 : Global Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 3 : Global Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 4 : Global Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 5 : Global Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 6 : Global Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 7 : Global Neglected Tropical Disease Treatment Market, by Value, by Region, 2020
Figure 8 : Global Neglected Tropical Disease Treatment Market, by Value, by Company, 2020
Figure 9 : Global Neglected Tropical Disease Treatment Market, Product Map, 2020
Figure 10 : North America Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 11 : North America Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 12 : North America Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 13 : North America Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 14 : North America Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 15 : North America Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
Figure 16 : Europe Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 17 : Europe Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 18 : Europe Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 19 : Europe Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 20 : Europe Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 21 : Europe Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
Figure 22 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 23 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 24 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 25 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 26 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 27 : Asia-Pacific Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
Figure 28 : South America Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 29 : South America Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 30 : South America Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 31 : South America Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 32 : South America Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 33 : South America Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
Figure 34 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, 2019-2026
Figure 35 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Disease, 2019-2026
Figure 36 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Product Type, 2019-2026
Figure 37 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Route of Administration, 2019-2026
Figure 38 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by End-User, 2019-2026
Figure 39 : Middle East & Africa Neglected Tropical Disease Treatment Market, by Value, by Country, 2020
Figure 40 : F. Hoffmann-La Roche AG: Revenue Share, 2020
Figure 41 : Sanofi S.A.: Revenue Share, 2020
Figure 42 : Eisai Co. Ltd.: Revenue Share, 2020
Figure 43 : Pfizer, Inc.: Revenue Share, 2020
Figure 44 : Novartis International AG: Revenue Share, 2020
Figure 45 : GlaxoSmithKline plc: Revenue Share, 2020
Figure 46 : Bayer AG: Revenue Share, 2020
Figure 47 : Abbott Laboratories: Revenue Share, 2020
Figure 48 : StratifiCare Pte. Ltd.: Revenue Share, 2020
Figure 49 : Takeda Pharmaceutical Company Limited: Revenue Share, 2020

Neglected Tropical Disease Treatment Market

Single User License: $5500

* Please allow 10 business days for delivery of this report

Enquiry Before Buying

Neglected Tropical Disease Treatment Market

QUICK LINKS

CUSTOMER SERVICES

ADDRESS

Neglected Tropical Disease Treatment Market

Neglected Tropical Diseases Drugs And Vaccines Market

Fabry Disease Treatment Market

Lymphoma Treatment

Rosacea Treatment Market

Acromegaly Treatment Market

QUICK LINKS

CUSTOMER SERVICES

ADDRESS